pubmed-article:17408548 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0001430 | lld:lifeskim |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0009404 | lld:lifeskim |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0334044 | lld:lifeskim |
pubmed-article:17408548 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:17408548 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:17408548 | pubmed:dateCreated | 2007-4-5 | lld:pubmed |
pubmed-article:17408548 | pubmed:abstractText | Patients with advanced adenomas (AA) have a high risk of developing advanced colorectal neoplasms. Therefore, shorter monitoring intervals have been recommended in this patient subgroup. High grade dysplasia (HGD) is the main marker of cancer transformation. However, its predictive value for developing advanced neoplams in patients with advanced adenoma is unknown. | lld:pubmed |
pubmed-article:17408548 | pubmed:language | spa | lld:pubmed |
pubmed-article:17408548 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17408548 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17408548 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17408548 | pubmed:month | Apr | lld:pubmed |
pubmed-article:17408548 | pubmed:issn | 0210-5705 | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:RamírezFranci... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:PiquéJosep... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:CastellsAnton... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:BordasJosep... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:LlachJosepJ | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:PelliséMariaM | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:PetitAnnaA | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:Gimeno-García... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:BalaguerFranc... | lld:pubmed |
pubmed-article:17408548 | pubmed:author | pubmed-author:GonzaloVictòr... | lld:pubmed |
pubmed-article:17408548 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17408548 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:17408548 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17408548 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17408548 | pubmed:pagination | 207-11 | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:meshHeading | pubmed-meshheading:17408548... | lld:pubmed |
pubmed-article:17408548 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17408548 | pubmed:articleTitle | [High-grade dysplasia as a risk factor of metachronous advanced colorectal neoplasms in patients with advanced adenomas]. | lld:pubmed |
pubmed-article:17408548 | pubmed:affiliation | Servicio de Gastroenterología, Institut de Malalties Digestives, Hospital Clínic, Universitat de Barcelona, Barcelona, España. | lld:pubmed |
pubmed-article:17408548 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17408548 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:17408548 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:17408548 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |